Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

Journal of Investigative Dermatology

Volumn 137, Issue 1, 2017, Pages 18-25

  Brunner, Patrick M ^a   Silverberg, Jonathan I ^b   Guttman Yassky, Emma ^c   Paller, Amy S ^b   Kabashima, Kenji ^d   Amagai, Masayuki ^e   Luger, Thomas A ^f   Deleuran, Mette ^g   Werfel, Thomas ^h   Eyerich, Kilian ⁱ   Stingl, Georg ^j   Bagot, Martine ^k   Hijnen, Dirk Jan ^k   Ardern Jones, Michael ^k   Reynolds, Nick ^k   Spuls, Phyllis ^k   Taieb, Alain ^k  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j Universitatsklinik fur Dermatologie   (Austria)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOGLOBULIN E; INTERLEUKIN 22; INTERLEUKIN 25; INTERLEUKIN 33;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALOPECIA AREATA; ANXIETY; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; AUTISM; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; COMORBIDITY; DENDRITIC CELL; DEPRESSION; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EPIDERMIS HYPERPLASIA; FOOD ALLERGY; HAND ECZEMA; HUMAN; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; KAPOSI VARICELLIFORM ERUPTION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; SKIN ALLERGY; SYSTEMIC DISEASE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS INFECTION; ASTHMA; BACTERIAL INFECTIONS; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; EOSINOPHILIC ESOPHAGITIS; FEMALE; FOOD HYPERSENSITIVITY; IMMUNOLOGY; INCIDENCE; MALE; PATHOPHYSIOLOGY; PROGNOSIS; RHINITIS, ALLERGIC;

ASTHMA; BACTERIAL INFECTIONS; COMORBIDITY; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; EOSINOPHILIC ESOPHAGITIS; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; INCIDENCE; MALE; PROGNOSIS; RHINITIS, ALLERGIC;

EID: 85006822994     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.08.022     Document Type: Short Survey

References (130)

1. Andersen, Y.M., Egeberg, A., Gislason, G.H., Hansen, P.R., Skov, L., Thyssen, J.P., Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol 138 (2016), 310–312.
2. Arellano, F.M., Arana, A., Wentworth, C.E., Fernandez-Vidaurre, C., Schlienger, R.G., Conde, E., Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 123 (2009), 1111–1116.
3. Arellano, F.M., Wentworth, C.E., Arana, A., Fernandez, C., Paul, C.F., Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 127 (2007), 808–816.
4. Arima, M., Shimizu, Y., Sowa, J., Narita, T., Nishi, I., Iwata, N., et al. Psychosomatic analysis of atopic dermatitis using a psychological test. J Dermatol 32 (2005), 160–168.
5. Bath-Hextall, F.J., Birnie, A.J., Ravenscroft, J.C., Williams, H.C., Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 163 (2010), 12–26.
6. Beck, L.A., Boguniewicz, M., Hata, T., Schneider, L.C., Hanifin, J., Gallo, R., et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 124 (2009), 260–269.
7. Belgrave, D.C., Granell, R., Simpson, A., Guiver, J., Bishop, C., Buchan, I., et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med, 11, 2014, e1001748.
8. Belkaid, Y., Segre, J.A., Dialogue between skin microbiota and immunity. Science 346 (2014), 954–959.
9. Beygi, S., Lajevardi, V., Abedini, R., C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol 28 (2014), 700–711.
10. Blackman, J.A., Gurka, M.J., Gurka, K.K., Oliver, M.N., Emotional, developmental and behavioural co-morbidities of children with chronic health conditions. J Paediatr Child Health 47 (2011), 742–747.
11. Blaydon, D.C., Biancheri, P., Di, W.L., Plagnol, V., Cabral, R.M., Brooke, M.A., et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365 (2011), 1502–1508.
12. Boguniewicz, M., Leung, D.Y., Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125 (2010), 4–13.
13. Brandt, E.B., Sivaprasad, U., Th2 cytokines and atopic dermatitis. J Clin Cell Immunol, 2, 2011, 110.
14. Brown, S.J., Sandilands, A., Zhao, Y., Liao, H., Relton, C.L., Meggitt, S.J., et al. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol 128 (2008), 1591–1594.
15. Buske-Kirschbaum, A., Schmitt, J., Plessow, F., Romanos, M., Weidinger, S., Roessner, V., Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 38 (2013), 12–23.
16. Carson, C.G., Rasmussen, M.A., Thyssen, J.P., Menne, T., Bisgaard, H., Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One, 7, 2012, e48678.
17. Chen, M.H., Su, T.P., Chen, Y.S., Hsu, J.W., Huang, K.L., Chang, W.H., et al. Is atopy in early childhood a risk factor for ADHD and ASD? A longitudinal study. J Psychosom Res 77 (2014), 316–321.
18. Cheng, J., Zens, M.S., Duell, E., Perry, A.E., Chapman, M.S., Karagas, M.R., History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 24 (2015), 749–754.
19. Chockalingam, R., Downing, C., Tyring, S.K., Cutaneous squamous cell carcinomas in organ transplant recipients. J Clin Med 4 (2015), 1229–1239.
20. Chrostowska-Plak, D., Reich, A., Szepietowski, J.C., Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol 27 (2013), e239–e242.
21. Cogen, A.L., Yamasaki, K., Muto, J., Sanchez, K.M., Crotty Alexander, L., Tanios, J., et al. Staphylococcus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS One, 5, 2010, e8557.
22. + TH22/TC22 cell subsets. J Allergy Clin Immunol 136 (2015), 941–951.
23. Czarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 136 (2015), 104–115.
24. Czarnowicki, T., Malajian, D., Khattri, S., da Rosa, J.C., Dutt, R., Finney, R., et al. Petrolatum: barrier repair and antimicrobial responses underlying this “inert” moisturizer. J Allergy Clin Immunol 137 (2016), 1091–1102.
25. Czarnowicki, T., Malajian, D., Shemer, A., Fuentes-Duculan, J., Gonzalez, J., Suarez-Farinas, M., et al. Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis. J Allergy Clin Immunol 136 (2015), 208–211.
26. Dalgard, F.J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G.B., et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 135 (2015), 984–991.
27. Deckert, S., Kopkow, C., Schmitt, J., Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 69 (2014), 37–45.
28. Dieris-Hirche, J., Gieler, U., Kupfer, J.P., Milch, W.E., Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 60 (2009), 641–646.
29. Drucker AM, Li WQ, Cho E, Li T, Sun Q, Camargo CA, Jr., et al. Atopic dermatitis is not independently associated with non-fatal myocardial infarction or stroke among US women [e-pub ahead of print]. Allergy 2016;71:1496–500.
30. Eichenfield, L.F., Ellis, C.N., Mancini, A.J., Paller, A.S., Simpson, E.L., Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg 31 (2012), S3–S5.
31. Ellinghaus, D., Baurecht, H., Esparza-Gordillo, J., Rodriguez, E., Matanovic, A., Marenholz, I., et al. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 45 (2013), 808–812.
32. Esaki, H., Brunner, P.M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., et al. Early onset pediatric atopic dermatitis is Th2, but also Th17 polarized in skin. J Allergy Clin Immunol, 136(5 Suppl. 1), 2016, S7.
33. Fu, S.L., Pierre, J., Smith-Norowitz, T.A., Hagler, M., Bowne, W., Pincus, M.R., et al. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 153 (2008), 401–409.
34. Fukunaga, N., Okada, Y., Konishi, Y., Murashita, T., Koyama, T., Pay attention to valvular disease in the presence of atopic dermatitis. Circ J 77 (2013), 1862–1866.
35. Garmhausen, D., Hagemann, T., Bieber, T., Dimitriou, I., Fimmers, R., Diepgen, T., et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 68 (2013), 498–506.
36. Gittler, J.K., Shemer, A., Suarez-Farinas, M., Fuentes-Duculan, J., Gulewicz, K.J., Wang, C.Q., et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130 (2012), 1344–1354.
37. Gueniche, A., Knaudt, B., Schuck, E., Volz, T., Bastien, P., Martin, R., et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol 159 (2008), 1357–1363.
38. Gutowska-Owsiak, D., Schaupp, A.L., Salimi, M., Taylor, S., Ogg, G.S., Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol 165 (2011), 492–498.
39. Guttman-Yassky, E., Nograles, K.E., Krueger, J.G., Contrasting pathogenesis of atopic dermatitis and psoriasis—part I: clinical and pathologic concepts. J Allergy Clin Immunol 127 (2011), 1110–1118.
40. Guttman-Yassky, E., Nograles, K.E., Krueger, J.G., Contrasting pathogenesis of atopic dermatitis and psoriasis—part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 127 (2011), 1420–1432.
41. Haeck, I.M., Knol, M.J., Ten Berge, O., van Velsen, S.G., de Bruin-Weller, M.S., Bruijnzeel-Koomen, C.A., Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 64 (2011), 1074–1084.
42. Hajdarbegovic, E., Blom, H., Verkouteren, J.A., Hofman, A., Hollestein, L., Nijsten, T., Atopic dermatitis is not associated with actinic keratosis: cross-sectional results from the Rotterdam study. Br J Dermatol 175 (2016), 89–94.
43. Hanifin, J.M., Rajka, G., Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 (1980), 44–47.
44. Hayashida, S., Uchi, H., Takeuchi, S., Esaki, H., Moroi, Y., Furue, M., Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis. J Dermatol Sci 61 (2011), 78–79.
45. Hjuler, K.F., Bottcher, M., Vestergaard, C., Deleuran, M., Raaby, L., Botker, H.E., et al. Increased prevalence of coronary artery disease in severe psoriasis and severe atopic dermatitis. Am J Med 128 (2015), 1325–1334.
46. Horimukai, K., Morita, K., Narita, M., Kondo, M., Kitazawa, H., Nozaki, M., et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 134 (2014), 824–830.
47. Howell, M.D., Kim, B.E., Gao, P., Grant, A.V., Boguniewicz, M., Debenedetto, A., et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120 (2007), 150–155.
48. Huang, J.T., Abrams, M., Tlougan, B., Rademaker, A., Paller, A.S., Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123 (2009), e808–e814.
49. Huang, J.T., Rademaker, A., Paller, A.S., Dilute bleach baths for Staphylococcus aureus colonization in atopic dermatitis to decrease disease severity. Arch Dermatol 147 (2011), 246–247.
50. Hui, R.L., Lide, W., Chan, J., Schottinger, J., Yoshinaga, M., Millares, M., Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother 43 (2009), 1956–1963.
51. Hvid, M., Vestergaard, C., Kemp, K., Christensen, G.B., Deleuran, B., Deleuran, M., IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?. J Invest Dermatol 131 (2011), 150–157.
52. Irvine, A.D., McLean, W.H., Leung, D.Y., Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365 (2011), 1315–1327.
53. Ishiuji, Y., Coghill, R.C., Patel, T.S., Oshiro, Y., Kraft, R.A., Yosipovitch, G., Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 161 (2009), 1072–1080.
54. Jahnz-Rozyk, K., Targowski, T., Paluchowska, E., Owczarek, W., Kucharczyk, A., Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60 (2005), 685–688.
55. Jones, A.L., Curran-Everett, D., Leung, D.Y., Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis. J Allergy Clin Immunol 137 (2016), 1247–1248.
56. Josephs, D.H., Spicer, J.F., Corrigan, C.J., Gould, H.J., Karagiannis, S.N., Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy 43 (2013), 1110–1123.
57. Kelleher, M., Dunn-Galvin, A., Hourihane, J.O., Murray, D., Campbell, L.E., McLean, W.H., et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol 135 (2015), 930–935.
58. Kelleher, M.M., Dunn-Galvin, A., Gray, C., Murray, D.M., Kiely, M., Kenny, L., et al. Skin barrier impairment at birth predicts food allergy at 2 years of age. J Allergy Clin Immunol 137 (2016), 1111–1116.
59. Kiecolt-Glaser, J.K., Belury, M.A., Andridge, R., Malarkey, W.B., Glaser, R., Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25 (2011), 1725–1734.
60. Kim, K., Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin. Biomol Ther (Seoul) 20 (2012), 506–512.
61. Kim, W.J., Lee, H.L., Lee, S.C., Kim, Y.T., Kim, H., Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164 (2000), 209–213.
62. Kobayashi, T., Glatz, M., Horiuchi, K., Kawasaki, H., Akiyama, H., Kaplan, D.H., et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 42 (2015), 756–766.
63. Kong, H.H., Oh, J., Deming, C., Conlan, S., Grice, E.A., Beatson, M.A., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22 (2012), 850–859.
64. Kubo, A., Nagao, K., Amagai, M., Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 122 (2012), 440–447.
65. Lai, Y., Cogen, A.L., Radek, K.A., Park, H.J., Macleod, D.T., Leichtle, A., et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 130 (2010), 2211–2221.
66. Legendre, L., Barnetche, T., Mazereeuw-Hautier, J., Meyer, N., Murrell, D., Paul, C., Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol 72 (2015), 992–1002.
67. Leung, D.Y., New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 62 (2013), 151–161.
68. Leung, D.Y., Guttman-Yassky, E., Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 134 (2014), 769–779.
69. Leung, T.H., Zhang, L.F., Wang, J., Ning, S., Knox, S.J., Kim, S.K., Topical hypochlorite ameliorates NF-kappaB-mediated skin diseases in mice. J Clin Invest 123 (2013), 5361–5370.
70. Leyden, J.J., Marples, R.R., Kligman, A.M., Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90 (1974), 525–530.
71. Linabery, A.M., Jurek, A.M., Duval, S., Ross, J.A., The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol 171 (2010), 749–764.
72. Luger, T., Boguniewicz, M., Carr, W., Cork, M., Deleuran, M., Eichenfield, L., et al. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol 26 (2015), 306–315.
73. Margolis, D.J., Abuabara, K., Hoffstad, O.J., Wan, J., Raimondo, D., Bilker, W.B., Association between malignancy and topical use of pimecrolimus. JAMA Dermatol 151 (2015), 594–599.
74. Martin, J.C., Baeten, D.L., Josien, R., Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol 154 (2014), 1–12.
75. Mathes, E.F., Oza, V., Frieden, I.J., Cordoro, K.M., Yagi, S., Howard, R., et al. “Eczema coxsackium” and unusual cutaneous findings in an enterovirus outbreak. Pediatrics 132 (2013), e149–e157.
76. McAleer, M.A., Irvine, A.D., The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 131 (2013), 280–291.
77. Metz, M., Wahn, U., Gieler, U., Stock, P., Schmitt, J., Blume-Peytavi, U., Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians. Pediatr Allergy Immunol 24 (2013), 527–539.
78. Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M.J., Salcedo, R., Kastenmuller, W., et al. Compartmentalized control of skin immunity by resident commensals. Science 337 (2012), 1115–1119.
79. Niebuhr, M., Scharonow, H., Gathmann, M., Mamerow, D., Werfel, T., Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis. J Allergy Clin Immunol 126 (2010), 1176–1183.
80. Nijsten, T., Wakkee, M., Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 129 (2009), 1601–1603.
81. Oh, S.H., Roh, H.J., Kwon, J.E., Lee, S.H., Kim, J.Y., Choi, H.J., et al. Expression of interleukin-17 is correlated with interferon-alpha expression in cutaneous lesions of lupus erythematosus. Clin Exp Dermatol 36 (2011), 512–520.
82. Patel, D., Jahnke, M.N., Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol 32 (2015), 792–796.
83. Pellerin, L., Henry, J., Hsu, C.Y., Balica, S., Jean-Decoster, C., Mechin, M.C., et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol 131 (2013), 1094–1102.
84. Platzer, B., Elpek, K.G., Cremasco, V., Baker, K., Stout, M.M., Schultz, C., et al. IgE/FcεRI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses. [e-pub ahead of print] Cell Rep, 2015 http://dx.doi.org/10.1016/j.celrep.2015.02.015 (accessed September 21, 2016).
85. Pollak, Y., Yirmiya, R., Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5 (2002), 389–399.
86. Raap, U., Weissmantel, S., Gehring, M., Eisenberg, A.M., Kapp, A., Folster-Holst, R., IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 23 (2012), 285–288.
87. Raison, C.L., Capuron, L., Miller, A.H., Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27 (2006), 24–31.
88. Riis, J.L., Vestergaard, C., Deleuran, M.S., Olsen, M., Childhood atopic dermatitis and risk of attention deficit/hyperactivity disorder: a cohort study. J Allergy Clin Immunol 138 (2016), 608–610.
89. Rosenkranz, M.A., Busse, W.W., Johnstone, T., Swenson, C.A., Crisafi, G.M., Jackson, M.M., et al. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci USA 102 (2005), 13319–13324.
90. Salimi, M., Barlow, J.L., Saunders, S.P., Xue, L., Gutowska-Owsiak, D., Wang, X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
91. Sanna, L., Stuart, A.L., Pasco, J.A., Jacka, F.N., Berk, M., Maes, M., et al. Atopic disorders and depression: findings from a large, population-based study. J Affect Disord 155 (2014), 261–265.
92. Saunders, S.P., Moran, T., Floudas, A., Wurlod, F., Kaszlikowska, A., Salimi, M., et al. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J Allergy Clin Immunol 137 (2016), 482–491.
93. Schmitt, J., Buske-Kirschbaum, A., Roessner, V., Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 65 (2010), 1506–1524.
94. Schmitt, J., Schwarz, K., Baurecht, H., Hotze, M., Folster-Holst, R., Rodriguez, E., et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 137 (2016), 130–136.
95. Schmitt, J., Weidinger, S., Alternative models of comorbidity: a framework for the interpretation of epidemiological association studies. J Invest Dermatol 134 (2014), 303–307.
96. Schneider, L., Hanifin, J., Boguniewicz, M., Eichenfield, L.F., Spergel, J.M., Dakovic, R., et al. Study of the atopic march: development of atopic co-morbidities. Pediatr Dermatol 33 (2016), 388–398.
97. Schut, C., Bosbach, S., Gieler, U., Kupfer, J., Personality traits, depression and itch in patients with atopic dermatitis in an experimental setting: a regression analysis. Acta Derm Venereol 94 (2014), 20–25.
98. Seite, S., Flores, G.E., Henley, J.B., Martin, R., Zelenkova, H., Aguilar, L., et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol 13 (2014), 1365–1372.
99. Senra, M.S., Wollenberg, A., Psychodermatological aspects of atopic dermatitis. Br J Dermatol 170:Suppl. 1 (2014), 38–43.
100. Silverberg, J.I., Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 70 (2015), 1300–1308.
101. Silverberg, J.I., Becker, L., Kwasny, M., Menter, A., Cordoro, K.M., Paller, A.S., Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol 151 (2015), 144–152.
102. Silverberg, J.I., Greenland, P., Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 135 (2015), 721–728.
103. Silverberg, J.I., Silverberg, N.B., Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol 133 (2014), 1041–1047.
104. Silverberg, J.I., Simpson, E.L., Association between obesity and eczema prevalence, severity and poorer health in US adolescents. Dermatitis 25 (2014), 172–181.
105. Simon, D., Bieber, T., Systemic therapy for atopic dermatitis. Allergy 69 (2014), 46–55.
106. Simpson, E.L., Chalmers, J.R., Hanifin, J.M., Thomas, K.S., Cork, M.J., McLean, W.H., et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 134 (2014), 818–823.
107. Simpson, E.L., Eichenfield, L.F., Ellis, C.N., Mancini, A.J., Paller, A.S., Current issues in atopic comorbidities and preventing the atopic march. Semin Cutan Med Surg 31 (2012), S6–S9.
108. Soumelis, V., Reche, P.A., Kanzler, H., Yuan, W., Edward, G., Homey, B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002), 673–680.
109. Stander, S., Pogatzki-Zahn, E., Stumpf, A., Fritz, F., Pfleiderer, B., Ritzkat, A., et al. Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol 95 (2015), 266–271.
110. Strom, M., Silverberg, J.I., Associations of physical activity and sedentary behavior with atopic disease in US children. J Pediatr 174 (2016), 247–253.
111. Su, V.Y., Chen, T.J., Yeh, C.M., Chou, K.T., Hung, M.H., Chu, S.Y., et al. Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study. Ann Med 46 (2014), 84–89.
112. Suarez, A.L., Feramisco, J.D., Koo, J., Steinhoff, M., Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol 92 (2012), 7–15.
113. Suarez-Farinas, M., Tintle, S.J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127 (2011), 954–964.
114. Sugiura, H., Omoto, M., Hirota, Y., Danno, K., Uehara, M., Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289 (1997), 125–131.
115. Tang, T.S., Bieber, T., Williams, H.C., Does “autoreactivity” play a role in atopic dermatitis?. J Allergy Clin Immunol 129 (2012), 1209–1215.
116. Tang, T.S., Bieber, T., Williams, H.C., Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful?. J Allergy Clin Immunol 133 (2014), 1615–1625.
117. Tennis, P., Gelfand, J.M., Rothman, K.J., Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165 (2011), 465–473.
118. Thyssen, J.P., Johansen, J.D., Linneberg, A., Menne, T., The epidemiology of hand eczema in the general population–prevalence and main findings. Contact Dermatitis 62 (2010), 75–87.
119. Thyssen, J.P., McFadden, J.P., Kimber, I., The multiple factors affecting the association between atopic dermatitis and contact sensitization. Allergy 69 (2014), 28–36.
120. Tominaga, M., Ogawa, H., Takamori, K., Histological characterization of cutaneous nerve fibers containing gastrin-releasing peptide in NC/Nga mice: an atopic dermatitis model. J Invest Dermatol 129 (2009), 2901–2905.
121. Volz, T., Skabytska, Y., Guenova, E., Chen, K.M., Frick, J.S., Kirschning, C.J., et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 134 (2014), 96–104.
122. Waxweiler, W.T., Agans, R., Morrell, D.S., Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil. Pediatr Dermatol 28 (2011), 689–694.
123. Weidinger, S., Novak, N., Atopic dermatitis. Lancet 387 (2016), 1109–1122.
124. Weidinger, S., Willis-Owen, S.A., Kamatani, Y., Baurecht, H., Morar, N., Liang, L., et al. A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22 (2013), 4841–4856.
125. Weisshaar, E., Diepgen, T.L., Bruckner, T., Fartasch, M., Kupfer, J., Lob-Corzilius, T., et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and Scoring Atopic Dermatitis severity in 823 children. Acta Derm Venereol 88 (2008), 234–239.
126. Wu, L.C., Hwang, C.Y., Chung, P.I., Hua, T.C., Chen, Y.D., Chu, S.Y., et al. Autoimmune disease comorbidities in patients with atopic dermatitis: a nationwide case-control study in Taiwan. Pediatr Allergy Immunol 25 (2014), 586–592.
127. Yaghmaie, P., Koudelka, C.W., Simpson, E.L., Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 131 (2013), 428–433.
128. Yarlagadda, A., Alfson, E., Clayton, A.H., The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 6 (2009), 18–22.
129. Zhang, A., Silverberg, J.I., Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol 72 (2015), 606–616.
130. Zimmerman, A.W., Jyonouchi, H., Comi, A.M., Connors, S.L., Milstien, S., Varsou, A., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33 (2005), 195–201.